Institutional Ownership
Sab Biotherapeutics Inc
CUSIP 78397T111*W EXP 10/22/202SABSWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
6
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Lmr Partners LLP | 539.6K | $14.1K |
| 2 | Morgan Stanley | 146.4K | $3.7K |
| 3 | Clear Street Group Inc. | 78.7K | $2.1K |
| 4 | Gts Securities LLC | 41.0K | $1.1K |
| 5 | Ubs Group AG | 4.2K | $105 |
| 6 | Wolverine Asset Management LLC | 1.8K | $47 |